Long-term survival in patients with metastatic renal cell carcinoma (mRCC) in the era of new targeted therapies: Five-year follow-up in a single Spanish medical institution (Genito-Urinary Tumor Unit, University Hospital 12 de Octubre).
G de Velasco Oria
No relevant relationships to disclose
J Sepulveda
No relevant relationships to disclose
F Villacampa
No relevant relationships to disclose
I Ghanem
No relevant relationships to disclose
Daniel E. Castellano
No relevant relationships to disclose